DIN 02486571 — HYPERRAB 300 UNIT
HYPERRAB is a solution of Rabies Immunoglobulin (Human) marketed by GRIFOLS THERAPEUTICS LLC. The full Rabies Immunoglobulin (Human) monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02486571
- Brand name
- HYPERRAB
- Active ingredient
- Rabies Immunoglobulin (Human)
- Strength
- 300 UNIT
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Manufacturer
- GRIFOLS THERAPEUTICS LLC
- Health Canada status
- MARKETED
- Drug class
- Passive immunizing agent (human rabies immunoglobulin)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Rabies Immunoglobulin (Human) products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02482436 | KAMRAB | 150 UNIT | SOLUTION | KAMADA LTD | MARKETED |